Scarica l'app Stockscreener
18.03
0.03%
-0.005
Dopo l'orario di chiusura:
17.80
-0.23
-1.28%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AVTX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$18.04
Aprire:
$18.27
Volume 24 ore:
108.22K
Relative Volume:
0.29
Capitalizzazione di mercato:
$237.14M
Reddito:
$1.93M
Utile/perdita netta:
$-7.96M
Rapporto P/E:
-0.00511
EPS:
-3530.8178
Flusso di cassa netto:
$-36.78M
1 W Prestazione:
+2.62%
1M Prestazione:
+41.86%
6M Prestazione:
+262.05%
1 anno Prestazione:
+38.59%
Intervallo 1D:
$17.53
$18.50
Intervallo di 1 settimana:
$16.77
$19.01
Portata 52W:
$3.39
$19.41
Avalo Therapeutics Inc Stock (AVTX) Company Profile
Nome
Avalo Therapeutics Inc
Settore
Industria
Telefono
410-522-8707
Indirizzo
1500 LIBERTY RIDGE DRIVE, WAYNE
Confronta AVTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTX
Avalo Therapeutics Inc
|
18.03 | 321.02M | 1.93M | -7.96M | -36.78M | -3,530.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Reiterato | H.C. Wainwright | Buy |
| 2025-09-05 | Iniziato | TD Cowen | Buy |
| 2025-08-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-02 | Ripresa | H.C. Wainwright | Buy |
| 2025-03-25 | Iniziato | Jefferies | Buy |
| 2025-03-25 | Iniziato | Stifel | Buy |
| 2025-02-28 | Iniziato | Piper Sandler | Overweight |
| 2025-02-21 | Iniziato | Wedbush | Outperform |
| 2024-12-19 | Iniziato | BTIG Research | Buy |
| 2024-10-24 | Iniziato | H.C. Wainwright | Neutral |
| 2024-04-16 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-09-24 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie
Can Avalo Therapeutics Inc. stock continue upward trendPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com
Can Avalo Therapeutics Inc. stock sustain revenue growthJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
Why Avalo Therapeutics Inc. stock remains on watchlists2025 Price Momentum & Weekly High Return Forecasts - newser.com
What analyst consensus says on Avalo Therapeutics Inc. stockMarket Rally & AI Driven Price Predictions - newser.com
Why Avalo Therapeutics Inc. (C6K0) stock stays resilient2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com
Multi factor analysis applied to Avalo Therapeutics Inc.Quarterly Investment Review & Precise Buy Zone Identification - newser.com
Will Avalo Therapeutics Inc. stock keep outperforming rivalsWeekly Profit Analysis & AI Based Trade Execution Alerts - newser.com
Using data filters to optimize entry into Avalo Therapeutics Inc.Market Sentiment Report & Real-Time Volume Analysis - newser.com
Full technical analysis of Avalo Therapeutics Inc. stockQuarterly Performance Summary & Daily Volume Surge Signals - newser.com
Will Avalo Therapeutics Inc. (C6K0) stock keep high P E multiplesTrade Analysis Report & Weekly Momentum Picks - newser.com
Is Avalo Therapeutics Inc. (C6K0) stock positioned for secular growthEarnings Miss & Consistent Profit Trading Strategies - newser.com
Real time social sentiment graph for Avalo Therapeutics Inc.Earnings Recap Summary & Entry Point Confirmation Signals - newser.com
How to monitor Avalo Therapeutics Inc. with trend dashboardsJuly 2025 Institutional & Growth Focused Entry Reports - newser.com
Can Avalo Therapeutics Inc. (C6K0) stock sustain revenue momentumCPI Data & Weekly Breakout Stock Alerts - newser.com
Why Avalo Therapeutics Inc. (C6K0) stock remains top ratedJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Will Avalo Therapeutics Inc. stock deliver long term returnsJuly 2025 Trends & Weekly Market Pulse Alerts - newser.com
What drives Avalo Therapeutics Inc stock priceWeekly Market Snapshot & Boost Wealth With Growth - earlytimes.in
Avalo Therapeutics (AVTX) to Release Quarterly Earnings on Thursday - MarketBeat
Is a relief rally coming for Avalo Therapeutics Inc. holdersWeekly Market Summary & Safe Capital Allocation Plans - newser.com
Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX) - Insider Monkey
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa - The Manila Times
Avalo Therapeutics Completes Enrollment in Phase 2 LOTUS Trial - TradingView
Avalo Therapeutics Announces Completion of Enrollment in - GlobeNewswire
Will Avalo Therapeutics Inc. stock deliver consistent dividendsWeekly Volume Report & Risk Controlled Daily Trade Plans - fcp.pa.gov.br
We Think Avalo Therapeutics (NASDAQ:AVTX) Can Afford To Drive Business Growth - Yahoo Finance
Can Avalo Therapeutics Inc. stock double in next 5 yearsWeekly Trading Summary & Fast Moving Stock Watchlists - fcp.pa.gov.br
Avalo Therapeutics Inc Azioni (AVTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):